Full Text View
Tabular View
No Study Results Posted
Related Studies
A Dose Escalation and Safety Study of I5NP in Patients Undergoing Major Cardiovascular Surgery
This study has been completed.
Study NCT00554359   Information provided by Quark Pharmaceuticals

First Received on November 4, 2007.   Last Updated on February 22, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Injury of Kidney
Acute Renal Failure
Additional conditions recognized in this trial
Acute Kidney Injury
Renal Insufficiency
More general conditions related to this trial
Kidney Diseases
Urologic Diseases
Interventions listed in this trial
I5NP (a small interfering RNA)
placebo
Sponsors listed in this trial
Quark Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services